Evidence map›Paper›PMID 23413816›Full record

ReviewAnnual review of chemical and biomolecular engineering2013

Synthetic biology: advancing the design of diverse genetic systems.

Yen-Hsiang Wang, Kathy Y Wei, Christina D Smolke

Abstract readReview
In one paragraph

Review in Annual review of chemical and biomolecular engineering, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. The switch-liker's guide to plant synthetic gene circuits.The Plant journal : for cell and molecular biology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Characterization ofPlants (Basel, Switzerland) · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yen-Hsiang WangDepartment of Bioengineering, Stanford University, Stanford, CA, USA. wangyh@stanford.edu
Kathy Y Wei
Christina D Smolke

Funding

Synthetic Biology Platforms for Natural Product Discovery and BiosynthesisDP1AT007886 · NCCIH · STANFORD UNIVERSITY · PI SMOLKE, CHRISTINA D · 2012 to 2016
$3.9M
NCCIH NIH HHS DP1 AT007886
6 · The paper itself

Abstract

A major objective of synthetic biology is to make the process of designing genetically encoded biological systems more systematic, predictable, robust, scalable, and efficient. Examples of genetic systems in the field vary widely in terms of operating hosts, compositional approaches, and network complexity, ranging from simple genetic switches to search-and-destroy systems. While significant advances in DNA synthesis capabilities support the construction of pathway- and genome-scale programs, several design challenges currently restrict the scale of systems that can be reasonably designed and implemented. Thus, while synthetic biology offers much promise in developing systems to address challenges faced in the fields of manufacturing, environment and sustainability, and health and medicine, the realization of this potential is currently limited by the diversity of available parts and effective design frameworks. As researchers make progress in bridging this design gap, advances in the field hint at ever more diverse applications for biological systems.

Indexed as

BioengineeringSynthetic BiologyAnimalsDNAGenomeHumansDNA

Identifiers

PMID23413816
PMCPMC3773533

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.